EP-NEC

Leads Biolabs Gains Japan Orphan Drug Designation for Opamtistomig

NANJING, China — September 28, 2026 Leads Biolabs announced that opamtistomig (LBL-024), its investigational PD-L1/4-1BB bispecific antibody, has received...

By cGxPwire Editor
September 29, 2026

Pharma

Leads Biolabs Secures Priority Review for Opamtistomig

NANJING, China | July 10, 2026 Nanjing Leads Biolabs Co., Ltd. has announced that the Center for Drug Evaluation...

By cGxPwire Editor
July 11, 2026

.Clinical

Leads Biolabs Wins Phase III Approval for Opamtistomig in Advanced EP-NEC

NANJING, China, May 18, 2026 Leads Biolabs announced that its proprietary PD-L1/4-1BB bispecific antibody Opamtistomig (LBL-024) has received approval...